| # | Title | Journal | Year | Citations |
|---|
| 1 | Vascular Access and All-Cause Mortality: A Propensity Score Analysis | Journal of the American Society of Nephrology: JASN | 2004 | 384 |
| 2 | Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis | Cell Death and Disease | 2016 | 215 |
| 3 | Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement | Medical Journal of Australia | 2012 | 179 |
| 4 | Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist | Kidney International | 1993 | 140 |
| 5 | Albuminuria is evident in the early stages of diabetes onset: Results from the Australian diabetes, obesity, and lifestyle study (AusDiab) | American Journal of Kidney Diseases | 2004 | 138 |
| 6 | Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) | Medical Journal of Australia | 2003 | 117 |
| 7 | Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations | Medical Journal of Australia | 2012 | 112 |
| 8 | ASK1 contributes to fibrosis and dysfunction in models of kidney disease | Journal of Clinical Investigation | 2018 | 104 |
| 9 | KHA‐CARI Guideline: Vascular access – central venous catheters, arteriovenous fistulae and arteriovenous grafts | Nephrology | 2013 | 93 |
| 10 | Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation | Transplantation | 2017 | 83 |
| 11 | Health-related quality of life in Australian adults with renal insufficiency: A population-based study | American Journal of Kidney Diseases | 2003 | 78 |
| 12 | Blockade of Macrophage Colony-Stimulating Factor Reduces Macrophage Proliferation and Accumulation in Renal Allograft Rejection | American Journal of Transplantation | 2003 | 72 |
| 13 | Vascular calcification and arterial stiffness in chronic kidney disease: Implications and management | Nephrology | 2007 | 71 |
| 14 | Clinical impact of genomic testing in patients with suspected monogenic kidney disease | Genetics in Medicine | 2021 | 70 |
| 15 | Compared with Younger Peritoneal Dialysis Patients, Elderly Patients have Similar Peritonitis-Free Survival and Lower Risk of Technique Failure, but Higher Risk of Peritonitis-Related Mortality | Peritoneal Dialysis International | 2011 | 66 |
| 16 | How Australian nephrologists view home dialysis: Results of a national survey | Nephrology | 2011 | 62 |
| 17 | Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease | Kidney International | 2013 | 59 |
| 18 | Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study | BMC Nephrology | 2009 | 58 |
| 19 | ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis | Journal of Cellular and Molecular Medicine | 2018 | 47 |
| 20 | An Interview Study of Patient and Caregiver Perspectives on Advance Care Planning in ESRD | American Journal of Kidney Diseases | 2018 | 46 |
| 21 | Serum 25-Hydroxyvitamin D Deficiency and the 5-Year Incidence of CKD | American Journal of Kidney Diseases | 2013 | 45 |
| 22 | The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled | Seminars in Dialysis | 2018 | 45 |
| 23 | Indoleamine 2,3-dioxygenase in transplantation (Review Article) | Nephrology | 2008 | 44 |
| 24 | The Outcomes of Patients with ESRD and ANCA-Associated Vasculitis in Australia and New Zealand | Clinical Journal of the American Society of Nephrology: CJASN | 2013 | 43 |
| 25 | Anthropometry Underestimates Body Protein Depletion in Haemodialysis Patients | Nephron | 1991 | 39 |
| 26 | A randomized, controlled trial of everolimus‐based dual immunosuppression versus standard of care in de novo kidney transplant recipients | Transplant International | 2014 | 39 |
| 27 | End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases | Nephrology Dialysis Transplantation | 2011 | 33 |
| 28 | Macrophages in Renal Injury | American Journal of Kidney Diseases | 1998 | 31 |
| 29 | Allocation of deceased donor kidneys: A review of international practices | Nephrology | 2019 | 31 |
| 30 | Trends in Hemodialysis Vascular Access From the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005 | American Journal of Kidney Diseases | 2007 | 29 |
| 31 | Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody‐mediated rejection | Nephrology | 2011 | 28 |
| 32 | Native arteriovenous fistula blood flow and resistance during hemodialysis | American Journal of Kidney Diseases | 2003 | 27 |
| 33 | Epidemiology of vascular access in the Australian hemodialysis population | Kidney International | 2003 | 27 |
| 34 | Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort | Internal Medicine Journal | 2015 | 25 |
| 35 | Perspectives on life participation by young adults with chronic kidney disease: an interview study | BMJ Open | 2020 | 23 |
| 36 | Severe Intestinal Involvement In Wegener's Granulomatosis | Journal of Gastroenterology and Hepatology (Australia) | 2003 | 22 |
| 37 | Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals | Nephrology Dialysis Transplantation | 2020 | 22 |
| 38 | IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1 | Journal of Immunology | 2020 | 22 |
| 39 | T cells and CD45R expression in B-chronic lymphocytic leukemia | Leukemia Research | 1990 | 21 |
| 40 | ARTERIAL CALCIFICATION AND STIFFNESS IN CHRONIC KIDNEY DISEASE | Clinical and Experimental Pharmacology and Physiology | 2007 | 21 |
| 41 | The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications | BMC Nephrology | 2015 | 21 |
| 42 | Early Peritoneal Dialysis Technique Failure: Review | Peritoneal Dialysis International | 2018 | 20 |
| 43 | Comparison of biochemical, haematological and volume parameters in two treatment schedules of nocturnal home haemodialysis | Nephrology | 2006 | 19 |
| 44 | Renal genetics in Australia: Kidney medicine in the genomic age | Nephrology | 2019 | 18 |
| 45 | Weekend Compared with Weekday Presentations of Peritoneal Dialysis–Associated Peritonitis | Peritoneal Dialysis International | 2012 | 16 |
| 46 | Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases | Kidney International Reports | 2021 | 15 |
| 47 | Determinants of native arteriovenous fistula blood flow | Nephrology | 2004 | 14 |
| 48 | Matrix metalloproteinase‐12 deficiency attenuates experimental crescentic anti‐glomerular basement membrane glomerulonephritis | Nephrology | 2018 | 13 |
| 49 | Renal anaemia: Recent developments, innovative approaches and future directions for improved management (Review Article) | Nephrology | 2006 | 12 |
| 50 | Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection | Nephrology | 2015 | 12 |
